K Ray Chaudhuri
Overview
Explore the profile of K Ray Chaudhuri including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
389
Citations
10971
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Landolfo S, Urso D, Santoro C, Batzu L, Gnoni V, Giugno A, et al.
J Neurol
. 2025 Mar;
272(4):264.
PMID: 40072620
Background: Fatigue is a common non-motor symptom (NMS) in Parkinson's disease (PD), affecting up to 50% of patients. It is suggested that PD-related fatigue may contribute to the burden perceived...
2.
Chaudhuri K, Poplawska-Domaszewicz K, Subramanian I, Jost W
J Neural Transm (Vienna)
. 2025 Feb;
PMID: 39954077
No abstract available.
3.
Vijiaratnam N, Girges C, Auld G, McComish R, King A, Skene S, et al.
Lancet
. 2025 Feb;
405(10479):627-636.
PMID: 39919773
Background: GLP-1 receptor agonists have neurotrophic properties in in-vitro and in-vivo models of Parkinson's disease and results of epidemiological studies and small randomised trials have suggested possible benefits for risk...
4.
Rukavina K, Staunton J, Zinzalias P, Krbot Skoric M, Wu K, Bannister K, et al.
PLoS One
. 2025 Jan;
20(1):e0316563.
PMID: 39808664
Fluctuation-related pain (FRP) affects more than one third of people with Parkinson's disease (PwP, PD) and has a harmful effect on health-related quality of life (HRQoL), but often remains under-reported...
5.
Poplawska-Domaszewicz K, Rota S, Qamar M, Chaudhuri K
Expert Rev Neurother
. 2025 Jan;
25(2):157-173.
PMID: 39773238
Introduction: We present a literature review on the clinical conundrums surrounding the differential diagnosis of restless legs syndrome (RLS, Willis-Ekbom disease), as well as conditions that can mimic RLS. An...
6.
Zhu S, Li H, Huang Z, Zeng Y, Huang J, Li G, et al.
NPJ Parkinsons Dis
. 2025 Jan;
11(1):1.
PMID: 39747089
In a prospective longitudinal study with 218 Parkinson's disease (PD) patients in the discovery cohort and 84 in the validation cohort, we aimed to identify novel blood biomarkers predicting disability...
7.
Poplawska-Domaszewicz K, Siuda J, Rudzinska-Bar M, Budrewicz S, Koziorowski D, Bogucki A, et al.
Neurol Neurochir Pol
. 2024 Dec;
58(6):608-616.
PMID: 39737586
Introduction: In Poland, not all forms of device-aided therapies for advanced Parkinson's Disease (APD) are currently available. Material And Methods: We aimed to produce a consensus recommendation from Polish movement...
8.
Metta V, Qamar M, Poplawska-Domaszewicz K, Ibrahim H, Hussain H, Nalarakettil A, et al.
J Neural Transm (Vienna)
. 2024 Dec;
132(4):591-601.
PMID: 39730960
Parkinson's disease (PD) is a progressive neurodegenerative disorder marked by both motor and non-motor symptoms that necessitate ongoing clinical evaluation and medication adjustments. Home-based wearable sensor monitoring offers a detailed...
9.
Deng X, Mehta A, Xiao B, Chaudhuri K, Tan E, Tan L
Parkinsonism Relat Disord
. 2024 Nov;
130():107208.
PMID: 39567305
Parkinson's disease (PD) is a complex neurodegenerative disorder with significant heterogeneity in disease presentation and progression. Subtype identification remains a top priority in the field of PD clinical research. Several...
10.
Poplawska-Domaszewicz K, Qamar M, Falup Pecurariu C, Chaudhuri K
Parkinsonism Relat Disord
. 2024 Nov;
129:107123.
PMID: 39489627
Early onset Parkinson's disease (EOPD) has been recently defined as a clinical entity with subjects presenting with Parkinson's disease (PD) between the ages of 21-50 and replaces the term Young...